Welcome to the e-CCO Library!

P470: Comparative effectiveness analysis of flares, hospitalisations, and corticosteroid use among biologic naïve patients with inflammatory bowel disease within 12 months of initiation of vedolizumab or infliximab
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Alam N.1, Raluy-Callado M.1, Gardstein B.2, Curtis R.3, Khalid J.M.*3

Created: Wednesday, 20 February 2019, 10:36 AM
P470: DUBLIN (Degree of Ulcerative colitis Burden of Luminal INflammation) score, a simple method to quantify inflammatory burden in ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

C. R. Rowan*1, G. Cullen1, H. E. Mulcahy1, J. Sheridan1, A. C. Moss2,3, E. J. Ryan1, G. A. Doherty1

Created: Friday, 22 February 2019, 9:41 AM
P470: Early change in faecal calprotectin during anti-TNFα initiation is strongly predictive of outcome in Crohn’s disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

P. Pavlidis*, G. Chung- Faye, P. Dubois, I. Bjarnason, B. H. Hayee

Created: Friday, 22 February 2019, 9:49 AM
P470: Evolution of asymptomatic unresected lesions in patients operated for multifocal Crohn's disease.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Abdalla, S.(1)*;Lelievre, O.(2);Carbonnel, F.(3);Penna, C.(4);Benoist, S.(5);Brouquet, A.(5);
Created: Friday, 14 July 2023, 11:05 AM
P470: Improving IBD-related pregnancy knowledge with a specialised preconception and pregnancy in IBD clinic
Year: 2018
Source: ECCO '18 Vienna
Authors:

N. Rodriguez, L. Ambrosio, L. Dieleman, B. Halloran, K.I. Kroeker, F. Peerani, K. Wong, R.N. Fedorak, V.W. Huang*

Created: Thursday, 21 February 2019, 9:14 AM
P470: Real-world characteristics and complications of patients with Ulcerative Colitis receiving conventional therapy in the public healthcare system in Brazil
Year: 2022
Source: ECCO'22
Authors: Galhardi Gasparini, R.(1);Yukie Sassaki, L.(2);Lima Martins, A.(3);Saad Hossne, R.(4);Watanabe de Oliveira, R.(5);Yang Santos, C.(6);Biatti Barreto, T.(7);
Created: Friday, 11 February 2022, 3:52 PM
P470: Ustekinumab Trough Levels are not Associated with Clinical Response in Inflammatory Bowel Disease Patients
Year: 2021
Source: ECCO'21 Virtual
Authors: Zelinkova, Z.(1);Lipovska, A.(2);Otottova, K.(2);Lucenicova, J.(3);Kadleckova, B.(2);
Created: Wednesday, 2 June 2021, 4:12 PM
P471 What is the appropriate cut-off value of CRP to predict endoscopic remission in ulcerative colitis patients with clinical remission?
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J. Shin, G. Seong, J.H. Song, S.M. Kong, T.J. Kim, E.R. Kim, S.N. Hong, D.K. Chang, Y.H. Kim

Created: Thursday, 30 January 2020, 10:12 AM
P471: A Transcriptome-dependent Prognostic Model of Response in Patients with Ulcerative Colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Johnson, T.(1);Reinisch, W.(2);Steere, B.(3);Milch, C.(4);Harris, C.(3);Morris, N.(3);D'Haens, G.(5);Huang, K.(1);Krishnan, V.(3)*;
Created: Friday, 14 July 2023, 11:05 AM
P471: Association of vedolizumab levels with clinical and biochemical markers of inflammation during maintenance therapy in inflammatory bowel disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

N. Plevris*1, G. R. Jones1, P. W. Jenkinson1, C. S. Chuah1, M. Lyons1, L. M. Merchant1, R. J. Pattenden1, I. D. Arnott1, C. W. Lees1

Created: Friday, 22 February 2019, 9:41 AM
P471: Clinical characteristics and complications in hospitalised elderly patients with ulcerative colitis in a real-world specialised hospital
Year: 2018
Source: ECCO '18 Vienna
Authors:

Y. Kita1*, A. Fujimori1, R. Koshiba1, K. Fujimoto1, T. Sato1, M. Kawai2, K. Kamikozuru1, T. Takagawa2, Y. Yukoyama1, T. Miyazaki1, K. Watanabe2, N. Hida1, S. Nakamura1

Created: Thursday, 21 February 2019, 9:14 AM
P471: Efficacy and safety of switching from reference infliximab to biosimilar infliximab in patients with inflammatory bowel disease: first French experience
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Soret P.-A.*1,2, Prieux-Klotz C.1, Avouac J.3, Molto A.3, Dior M.1, Brieau B.1, Dreanic J.1, Camus M.1, Barret M.1, Coriat R.1, Conort O.4, Chast F.4, Goulvestre C.5, Le Jeunne C.6, Dougados M.3, Nahon S.2, Chaussade S.1, Abitbol V.1

Created: Wednesday, 20 February 2019, 10:36 AM
P471: Predictors of bowel damage in long term progression of Crohn’s disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Fernandez Clotet, A.(1);Panes, J.(1);Ricart, E.(1);Castro Poceiro, J.(1);Masamunt, M.C.(1);Rodríguez, S.(2);Caballol, B.(1);Ordas, I.(1);Rimola, J.(2);
Created: Wednesday, 2 June 2021, 4:12 PM
P471: Real-world experience of using Tofacitinib in Ulcerative Colitis in biologic naïve and biologic exposed patients
Year: 2022
Source: ECCO'22
Authors: Cheesbrough, J.(1);Quraishi, M.N.(1);Sharma, N.(1);Nassar, I.(1);
Created: Friday, 11 February 2022, 3:52 PM
P471: Safety analysis of multimatrix mesalazine amongst patients with ulcerative colitis or recurrent diverticulitis ≥ 55 years of age
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

G. Lichtenstein1, K. Barrett2, D. Stefani-Hunyady3, F. Cataldi*4, J. Raskin5

Created: Friday, 22 February 2019, 9:49 AM
P472 Optimising the development of apps for the management of inflammatory bowel disease and participation in clinical trials
Year: 2020
Source:

ECCO'20 Vienna

Authors:

F. Hussain1, M. DeLegge2, M. Copeman3, M.B. Gallagher2, T. Stewart2, G. Georgiev4

Created: Thursday, 30 January 2020, 10:12 AM
P472: Changes in colectomy for Ulcerative Colitis during the last two decades: an in-depth retrospective analysis
Year: 2022
Source: ECCO'22
Authors: Le Cosquer, G.(1);Capirchio, L.(2);Rivière, P.(1);de Suray, N.(2);Poullenot, F.(1);De Vroey, B.(2);Berger, A.(1);Denis, M.A.(2);Zerbib, F.(1);Bachmann, R.(3);Remue, C.(3);Celerier, B.(4);Leonard, D.(3);Denost, Q.(4);Kartheuser, A.(3);Laharie, D.(1);Dewit, O.(2);
Created: Friday, 11 February 2022, 3:52 PM
P472: Cyclosporine versus infliximab in patients with Acute Severe Ulcerative Colitis: A single-centre retrospective study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Karpavičiūtė, V.(1)*;Kiudelis, G.(2);Kupčinskas, J.(2);Kupčinskas, L.(2);
Created: Friday, 14 July 2023, 11:05 AM
P472: Efficacy of intravenous ustekinumab re-induction in patients with Crohn’s disease with a loss of response
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

V. Heron*1,2, N. Panaccione3, K. Candido1, T. Bessissow1, A. Bitton1, C. Seow3, R. Panaccione3, W. Afif1

Created: Friday, 22 February 2019, 9:41 AM
P472: Faecal calprotectin as a biomarker of early mucosal healing in patients with ulcerative colitis naïve to adalimumab treatment
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

C. Muñoz Villafranca*1, A. Perez de Arenaza2, L. Gómez3, R. Higuera4, A. Munagorri5, M. A. Ogueta6, S. Ibañez7, J. Ortiz de Zárate8, O. Merino3, C. Rodriguez9, O. Nante9, P. Arreba10, P. Ramirez de la Piscina11, I. Rodríguez12, A. Bernal13, J. A. Arévalo13, J. L. Cabriada13

Created: Friday, 22 February 2019, 9:49 AM